Annual Shareholders Equity
$368.42 M
-$115.52 M-23.87%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual stockholders equity is $368.42 million, with the most recent change of -$115.52 million (-23.87%) on December 31, 2023.
- During the last 3 years, FATE annual shareholders equity has fallen by -$16.03 million (-4.17%).
- FATE annual shareholders equity is now -45.73% below its all-time high of $678.84 million, reached on December 31, 2021.
Performance
FATE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$362.33 M
-$34.66 M-8.73%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly stockholders equity is $362.33 million, with the most recent change of -$34.66 million (-8.73%) on September 30, 2024.
- Over the past year, FATE quarterly shareholders equity has dropped by -$40.45 million (-10.04%).
- FATE quarterly shareholders equity is now -54.14% below its all-time high of $790.10 million, reached on March 31, 2021.
Performance
FATE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FATE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.9% | -10.0% |
| 3 y3 years | -4.2% | -24.1% |
| 5 y5 years | +129.6% | +65.3% |
FATE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.7% | at low | -46.6% | at low |
| 5 y | 5-year | -45.7% | +50.5% | -54.1% | +65.3% |
| alltime | all time | -45.7% | +797.4% | -54.1% | +645.7% |
Fate Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $362.33 M(-8.7%) |
| Jun 2024 | - | $396.98 M(-6.8%) |
| Mar 2024 | - | $426.12 M(+15.7%) |
| Dec 2023 | $368.42 M(-23.9%) | $368.42 M(-8.5%) |
| Sep 2023 | - | $402.78 M(-8.0%) |
| Jun 2023 | - | $437.75 M(-8.3%) |
| Mar 2023 | - | $477.47 M(-1.3%) |
| Dec 2022 | $483.94 M(-28.7%) | $483.94 M(-6.6%) |
| Sep 2022 | - | $518.00 M(-10.8%) |
| Jun 2022 | - | $580.48 M(-8.4%) |
| Mar 2022 | - | $633.39 M(-6.7%) |
| Dec 2021 | $678.84 M(+76.6%) | $678.84 M(-7.1%) |
| Sep 2021 | - | $730.33 M(-2.9%) |
| Jun 2021 | - | $752.07 M(-4.8%) |
| Mar 2021 | - | $790.10 M(+105.5%) |
| Dec 2020 | $384.44 M(+57.1%) | $384.44 M(-9.4%) |
| Sep 2020 | - | $424.37 M(-10.5%) |
| Jun 2020 | - | $474.11 M(+116.3%) |
| Mar 2020 | - | $219.22 M(-10.4%) |
| Dec 2019 | $244.76 M(+52.5%) | $244.76 M(-8.7%) |
| Sep 2019 | - | $268.04 M(+110.2%) |
| Jun 2019 | - | $127.53 M(-12.6%) |
| Mar 2019 | - | $145.84 M(-9.1%) |
| Dec 2018 | $160.47 M | $160.47 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $173.93 M(+235.6%) |
| Jun 2018 | - | $51.83 M(-20.3%) |
| Mar 2018 | - | $65.00 M(-15.8%) |
| Dec 2017 | $77.19 M(+5.5%) | $77.19 M(+68.7%) |
| Sep 2017 | - | $45.75 M(-17.1%) |
| Jun 2017 | - | $55.21 M(-13.5%) |
| Mar 2017 | - | $63.86 M(-12.7%) |
| Dec 2016 | $73.15 M(+92.3%) | $73.15 M(+188.3%) |
| Sep 2016 | - | $25.37 M(+9.7%) |
| Jun 2016 | - | $23.13 M(-24.7%) |
| Mar 2016 | - | $30.73 M(-19.2%) |
| Dec 2015 | $38.04 M(+34.2%) | $38.04 M(-15.5%) |
| Sep 2015 | - | $44.99 M(-11.9%) |
| Jun 2015 | - | $51.07 M(+140.3%) |
| Mar 2015 | - | $21.25 M(-25.0%) |
| Dec 2014 | $28.34 M(-44.3%) | $28.34 M(-15.6%) |
| Sep 2014 | - | $33.58 M(-15.3%) |
| Jun 2014 | - | $39.64 M(-12.3%) |
| Mar 2014 | - | $45.18 M(-11.2%) |
| Dec 2013 | $50.85 M(-196.3%) | $50.85 M(-176.6%) |
| Sep 2013 | - | -$66.40 M(>+9900.0%) |
| Jun 2013 | - | -$150.00 K(-99.7%) |
| Dec 2012 | -$52.83 M(+4.2%) | -$52.83 M |
| Dec 2011 | -$50.68 M | - |
FAQ
- What is Fate Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Fate Therapeutics?
- What is Fate Therapeutics annual shareholders equity year-on-year change?
- What is Fate Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Fate Therapeutics?
- What is Fate Therapeutics quarterly shareholders equity year-on-year change?
What is Fate Therapeutics annual stockholders equity?
The current annual shareholders equity of FATE is $368.42 M
What is the all time high annual shareholders equity for Fate Therapeutics?
Fate Therapeutics all-time high annual stockholders equity is $678.84 M
What is Fate Therapeutics annual shareholders equity year-on-year change?
Over the past year, FATE annual stockholders equity has changed by -$115.52 M (-23.87%)
What is Fate Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of FATE is $362.33 M
What is the all time high quarterly shareholders equity for Fate Therapeutics?
Fate Therapeutics all-time high quarterly stockholders equity is $790.10 M
What is Fate Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, FATE quarterly stockholders equity has changed by -$40.45 M (-10.04%)